This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, C. U.
Right arrow Articles by Edwards, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, C. U.
Right arrow Articles by Edwards, K. M.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2007, p. 288-292, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00364-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Cellular Immunity in Adolescents and Adults following Acellular Pertussis Vaccine Administration{triangledown}

Claudius U. Meyer,1* Fred Zepp,1 Michael Decker,2,{dagger} Martin Lee,3 Swei-Ju Chang,3 Joel Ward,3 Sandra Yoder,4 Hugues Bogaert,5 and Kathryn M. Edwards4

Pediatric Immunology and Infectious Diseases, Children's Hospital, Johannes Gutenberg University of Mainz, Mainz, Germany,1 Department of Preventive Medicine, School of Medicine, Vanderbilt University, Nashville, Tennessee,2 Harbor-UCLA, Torrance, California,3 Division of Infectious Diseases, Department of Pediatrics, School of Medicine, Vanderbilt University, Nashville, Tennessee,4 GlaxoSmithKline, Rixensart, Belgium5

Received 5 October 2006/ Returned for modification 16 November 2006/ Accepted 16 January 2007

Cell-mediated immune (CMI) responses to an acellular pertussis vaccine administered to 49 subjects, a subset of participants in the National Institutes of Health-funded adult acellular pertussis vaccine efficacy trial, were evaluated and compared with antibody responses to vaccine antigens. Levels of proliferation of and cytokine secretion from lymphocytes cultured in the presence of pertussis toxin, filamentous hemagglutinin, or pertactin were measured before vaccination and 1 month and 1 year after vaccination. Statistically significant increases in lymphocyte stimulation indices and cytokine secretion were noted at both 1 month and 1 year after vaccination. Brisk pertussis antigen-specific immunoglobulin G responses were also noted at 1 month after vaccination, but these responses had declined by nearly 50% at 1 year after vaccination. These studies clearly demonstrate that both cellular and humoral immune responses occur after the administration of acellular pertussis vaccines to adolescents and adults but that the CMI responses are of greater magnitude and longer duration. CMI responses may be a better correlate of long-term protection.

* Corresponding author. Mailing address: Pediatric Immunology & Infectious Diseases, University Hospital Mainz, Obere Zahlbacher Str. 63, D-55131 Mainz, Germany. Phone: 49-6131-39-33331. Fax: 49-6131-39-33424. E-mail: meyer{at}uni-mainz.de.

{triangledown} Published ahead of print on 31 January 2007.

{dagger} Present address: Sanofi-Pasteur, Swiftwater, PA.

Clinical and Vaccine Immunology, March 2007, p. 288-292, Vol. 14, No. 3
1071-412X/07/$08.00+0     doi:10.1128/CVI.00364-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»